Related references
Note: Only part of the references are listed.The expression levels of miRNAs-27a and 23a in the peripheral blood mononuclear cells (PBMCs) and their correlation with FOXO1 and some inflammatory and anti-inflammatory cytokines in the patients with coronary artery disease (CAD)
Mohammad Babaee et al.
LIFE SCIENCES (2020)
Abdominal Fat SIRT6 Expression and Its Relationship with Inflammatory and Metabolic Pathways in Pre-Diabetic Overweight Patients
Nunzia D'Onofrio et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
A randomized controlled trial of metformin on left ventricular hypertrophy in patients with coronary artery disease without diabetes: the MET-REMODEL trial
Mohapradeep Mohan et al.
EUROPEAN HEART JOURNAL (2019)
MiR-27a promotes insulin resistance and mediates glucose metabolism by targeting PPAR-γ-mediated PI3K/AKT signaling
Tianbao Chen et al.
AGING-US (2019)
MicroRNAs and other non-coding RNAs in adipose tissue and obesity: emerging roles as biomarkers and therapeutic targets
Silvia Lorente-Cebrian et al.
CLINICAL SCIENCE (2019)
NGS Reveals Molecular Pathways Affected by Obesity and Weight Loss-Related Changes in miRNA Levels in Adipose Tissue
Alina Kurylowicz et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Inflammatory Cytokines and SIRT1 Levels in Subcutaneous Abdominal Fat: Relationship With Cardiac Performance in Overweight Pre-diabetics Patients
Celestino Sardu et al.
FRONTIERS IN PHYSIOLOGY (2018)
Anti-Angiogenic miR-222, miR-195, and miR-21a Plasma Levels in T1DM Are Improved by Metformin Therapy, Thus Elucidating Its Cardioprotective Effect: The MERIT Study
Fahad W. Ahmed et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
PROFILES OF CIRCULATING miRNAs FOLLOWING METFORMIN TREATMENT IN PATIENTS WITH TYPE 2 DIABETES
Ibrahim Halil Demirsoy et al.
JOURNAL OF MEDICAL BIOCHEMISTRY (2018)
Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy
Yu Zhang et al.
ENDOCRINE REVIEWS (2017)
Weight Loss Is Associated With Increased NAD+/SIRT1 Expression But Reduced PARP Activity in White Adipose Tissue
Elisabeth Rappou et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Silencing of miR-195 reduces diabetic cardiomyopathy in C57BL/6 mice
Dong Zheng et al.
DIABETOLOGIA (2015)
MicroRNA regulatory networks in human adipose tissue and obesity
Peter Arner et al.
NATURE REVIEWS ENDOCRINOLOGY (2015)
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
Roberto M. Lang et al.
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING (2015)
miR-195 regulates SIRT1-mediated changes in diabetic retinopathy
Rokhsana Mortuza et al.
DIABETOLOGIA (2014)
Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-responders
Raffaele Marfella et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Circulating miRNA Profiles in Patients with Metabolic Syndrome
Dwi Setyowati Karolina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Sirtuins as regulators of metabolism and healthspan
Riekelt H. Houtkooper et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
A role of miR-27 in the regulation of adipogenesis
Qun Lin et al.
FEBS JOURNAL (2009)
Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: A consensus statement from the American society of echocardiography carotid intima-media thickness task force endorsed by the society for vascular medicine
James H. Stein et al.
JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY (2008)
Share Paper
